PRINCE trial study shows blood test and PET imaging may help guide advanced prostate cancer treatment
A new collaborative study published in the Journal of Nuclear Medicine found that a blood-based tumour DNA test, used alongside PSMA PET scans, could help predict which patients are most likely to benefit from a combination of radioligand therapy and immunotherapy and provide an early indication of whether the treatment is working.
New Cancer Discovery Paper Identifies Germline CDK12 Variants in Aggressive Prostate Cancer
The Department of Urologic Sciences is pleased to share a new publication in Cancer Discovery titled, “Germline CDK12 variants in aggressive prostate cancer.” Dr. Sofie Tolmeijer and Dr. Alexander Wyatt The study identifies rare inherited CDK12 variants in patients with aggressive metastatic prostate cancer. These findings challenge the previous assumption that CDK12 alterations in prostate […]
UBC Researchers Publish High-Impact Study in PNAS
We are pleased to highlight a new publication in the Proceedings of the National Academy of Sciences (PNAS), one of the world’s most prestigious and widely cited scientific journals. A collaborative team led by Ersoy-Fazlioglu et al., including researchers from the Department of Urologic Sciences and the Vancouver Prostate Centre, has published a significant study […]
